Bio-Techne
TECH
584 hedge funds and large institutions have $9.29B invested in Bio-Techne in 2026 Q1 according to their latest regulatory filings, with 73 funds opening new positions, 199 increasing their positions, 224 reducing their positions, and 64 closing their positions.
14% more first-time investments, than exits
New positions opened: 73 | Existing positions closed: 64
3.07% more ownership
Funds ownership: 110.33% → 113.4% (+3.1%)
0% less funds holding
Funds holding: 585 → 584 (-1)
8% less capital invested
Capital invested by funds: $10.1B → $9.29B (-$823M)
11% less repeat investments, than reductions
Existing positions increased: 199 | Existing positions reduced: 224
33% less funds holding in top 10
Funds holding in top 10: 9 → 6 (-3)
42% less call options, than puts
Call options by funds: $56.4M | Put options by funds: $96.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$413M |
| 2 |
DCP
Durable Capital Partners
Bethesda,
Maryland
|
+$142M |
| 3 |
RCG
Ruane, Cunniff & Goldfarb
New York
|
+$116M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$94.2M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$74.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Select Equity Group
New York
|
-$128M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$97.7M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$65.3M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$49.4M |
| 5 |
BAMCO Inc
New York
|
-$38.8M |
TECH Hedge Fund Activity: Q1 2026 in Review
584 institutional investors reported a position in Bio-Techne (TECH) for Q1 2026, worth a combined $9.29B — down 8.1% from $10.1B a quarter earlier.
Buyers outnumbered sellers: 73 funds opened new TECH positions and 64 closed out — a net gain of 9 holders — while 199 added to existing stakes and 224 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $413M. The largest seller was Select Equity Group, cutting an estimated $128M.
- 584 institutional investors held Bio-Techne (TECH) as of Q1 2026, down from 585 in Q4 2025.
- Funds reported $9.29B of Bio-Techne stock for Q1 2026, down 8.1% quarter-over-quarter.
- 73 funds opened new Bio-Techne positions in Q1 2026 and 64 closed out, a net change of +9 holders.
- The largest Bio-Techne buyer in Q1 2026 was Fidelity Investments, an estimated $413M added.
- The largest Bio-Techne seller in Q1 2026 was Select Equity Group, an estimated $128M sold.
Based on aggregated 13F filings for Q1 2026.